Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndromeFeng Xu(Shanghai Sixth People's Hospital), Xiao Li(Shanghai Sixth People's Hospital)OncotargetJanuary 23, 201610.18632/oncotarget.6992Cited by 34SaveCiteExport RISWatch citationsRelated PapersRigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome|Scientific Reports|2014|49DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes|iScience|2023|9